VEGF-C–induced lymphangiogenesis also participates in antitumor immune responses and tumor metastasis, inflammatory bowel diseases, and neurodegenerative and neuroinflammatory diseases (2, 3). This evidence concerns the gene VEGFC and inflammatory bowel disease.